Despite government recommendations that health care professionals be vaccinated against the H1N1 influenza in order to protect patients, a significant number of workers intend to refuse the vaccine. Dr. Field reviews the legal status of the mandates for vaccination as well as viewpoints for and against compliance.
You are here
P&T® Journal contents for November 2009
Health Care & Law
Whose Rights Should Come First?
These days, it seems that just about everyone is emotionally attached to a brand-name electronic device, a designer T-shirt, or a gym bag with a pharma logo. The author, a reluctant consumer, ponders the power of brands.
Q & A
An Interview Series with Members of the ASHP Expert Panel on Formulary Management. Part 1: Linda S. Tyler, PharmD
In the first of a three-part series, topics such as drug approvals and shortages, therapeutic interchanges, and pharmacoeconomic assessments are discussed.
Agents for postmenopausal osteoporosis are reviewed.
FDA Public Health Alert
A Call for Heightened Vigilance and Monitoring
As a result of the contamination of unfractionated heparin, changes in the product’s potency have been made to ensure its purity and safety.
Topics include pralatrexate (Folotyn) for lymphoma; telavancin (Vibativ) for skin infections; and bepotastine besilate (Bepreve), an eyedrop for conjunctivitis.